4//SEC Filing
Salisbury Franklin Cary jr 4
Accession 0001104659-22-065266
CIK 0000895051other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:12 PM ET
Size
8.0 KB
Accession
0001104659-22-065266
Insider Transaction Report
Form 4
Salisbury Franklin Cary jr
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+388,387→ 388,387 totalExercise: $0.47Exp: 2032-05-25→ Common Stock (388,387 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of the year.
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeother
Related Parties
1- filerCIK 0001608627
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:12 PM ET
- Size
- 8.0 KB